Modra (Modulated Oral Drug Absorption) Pharmaceuticals B.V. is a spin-out from two internationally acclaimed centers of excellence in oncology, the ‘Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis (NKI-AVL)’ and the MC Slotervaart (Slotervaart) in Amsterdam. Modra Pharmaceuticals is a clinical stage company that develops new treatment paradigms by enabling oral bioavailability of existing anticancer drugs, “the iv to oral switch”, to improve cancer therapy and supportive care. Modra Pharmaceuticals has several products in preclinical and clinical development including oral formulations of docetaxel and paclitaxel.
Location: Netherlands, North Holland, Amsterdam
Employees: 1-10
Founded date: 2010
Investors 2
| Date | Name | Website |
| - | Waterman V... | watermanve... |
| - | Aglaia Onc... | aglaia-onc... |
Mentions in press and media 2
| Date | Title | Description |
| 06.07.2017 | We’re not done with chemotherapy, so why not improve it? | Based in the Netherlands, Modra Pharmaceuticals is taking aim at a group of chemotherapy agents known as taxanes, which include paclitaxel (Taxol) and docetaxel (Taxotere). Despite their widespread use, taxanes are poorly soluble — a charac... |
| - | We’re not done with chemotherapy, so why not improve it? | It’s hard to get excited about a modified chemotherapy drug in an era of personalized medicine, checkpoint inhibitors, and CAR-T immunotherapies. But it would be a mistake to not embrace a potential advance in this field, given the degree t... |